By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    medicare part d benefits
    Everything that You Need to Know About Medicare Part D
    August 15, 2022
    Best Ways to Boost Your Immune System this Winter
    Best Ways to Boost Your Immune System this Winter
    November 15, 2022
    back pain issues
    Ways to Treat Constant Back Pain
    August 21, 2023
    Latest News
    How Probate Planning Shapes the Future of Your Estate and Family Care
    July 17, 2025
    Beyond Nutrition: Everyday Foods That Support Whole-Body Health
    June 15, 2025
    The Wide-Ranging Benefits of Magnesium Supplements
    June 11, 2025
    The Best Home Remedies for Migraines
    June 5, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    More On Wellness Programs To Improve Health and Reduce Costs
    January 25, 2012
    Privatizing Social Security and Medicare: Who Can Defuse Political Dynamite?
    June 12, 2011
    Study: Risk of Death in Elderly Patients with Dementia Doubled with Some Antipsychotic Medications
    February 26, 2012
    Latest News
    How IT and Marketing Teams Can Collaborate to Protect Patient Trust
    July 17, 2025
    How Health Choices and Legal Actions Intersect After an Injury
    July 17, 2025
    How communities and healthcare providers can address slip and fall injuries with legal awareness
    July 17, 2025
    Let Your Lawyer Handle the Work Before You Pay Medical Costs
    July 6, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Obesity’s Outlook Unchanged
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Public Health > Obesity’s Outlook Unchanged
Public HealthTechnology

Obesity’s Outlook Unchanged

PatrickDriscoll
PatrickDriscoll
Share
3 Min Read
Image
SHARE

Drugs for the clinical treatment of obesity have taken hits over the past year.  Denied regulatory approvals, market withdrawals and the resulting industry moves, if projected going forward, leave an overall negative impression of the market.  However, describing the “current” market for obesity drugs based on the “past as prologue” would be an incomplete picture.

Drugs for the clinical treatment of obesity have taken hits over the past year.  Denied regulatory approvals, market withdrawals and the resulting industry moves, if projected going forward, leave an overall negative impression of the market.  However, describing the “current” market for obesity drugs based on the “past as prologue” would be an incomplete picture.  Certainly, the attitude of the FDA in rejecting Arena’s Lorcaserin and Orexigen’s Contrave, as well the withdrawal by Abbott of Meridia and similar developments have tempered the “optimism” of obesity drug developers.  But optimism remains, stemming from an overwhelming need and therefore opportunity for obesity drugs.  

 

More Read

ASH 2015: A Cancer Community of Hope
The Week in Health Care
Patient-Centric Care at the Hub of Telehealth
How to Progress Towards a “Prevention-Based Society”
mHealth Device Data to Eliminate Annual Checkup, Improve Disease Research

Source: “Products, Technologies and Markets Worldwide for the Clinical Management of Obesity, 2011-2019.” Report #S835 (copyright 2011, MedMarket Diligence, LLC).

Simultaneously, medical device development — restrictive devices, artificial fullness, malabsorption, gastric emptying, and appetite suppression devices — continue to see strong growth (i.e., double-digit CAGR) as approved devices see expanded indications (e.g., Lap Band) and new devices are steadily introduced to the market.

Surgical procedures and device implantation, however much they may avoid the challenges of drug complications (or just the FDA’s perceptions), are not free of challenges (including, of course, the need for surgery that is in many cases invasive), such as that there is a growing recognition that these are not permanent fixes and may require that expensive repeat procedures by done.

The short-term view of the obesity drug market is that it is “dead”, or at least on life support, but given the current market for obesity management products ($billions) and the indisputable accelerated growth in obesity prevalence and the recognition in the healthcare arena of obesity’s co-morbidity costs, one must conclude that the short-term view is not going to hold for very long at least not by many who are motivated by opportunity.

TAGGED:obesitypublic health
Share This Article
Facebook Copy Link Print
Share
By PatrickDriscoll
Follow:
I serve the interests of medical technology company decision-makers, venture-capitalists, and others with interests in medtech producing worldwide analyses of medical technology markets for my audience of mostly medical technology companies (but also rapidly growing audience of biotech, VC, and other healthcare decision-makers). I have a small staff and go to my industry insiders (or find new ones as needed) to produce detailed, reality-grounded analyses of current and potential markets and opportunities. I am principally interested in those core clinical applications served by medical devices, which are expanding to include biomaterials, drug-device hybrids and other non-device technologies either competing head-on with devices or being integrated with devices in product development. The effort and pain of making every analysis global in scope is rewarded by my audience's loyalty, since in the vast majority of cases they too have global scope in their businesses.Specialties: Business analysis through syndicated reports, and select custom engagements, on medical technology applications and markets in general/abdominal/thoracic surgery, interventional cardiology, cardiothoracic surgery, patient monitoring/management, wound management, cell therapy, tissue engineering, gene therapy, nanotechnology, and others.

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

Grounded Healing: A Natural Ally for Sustainable Healthcare Systems
How IT and Marketing Teams Can Collaborate to Protect Patient Trust
Global Healthcare Policy & Law
July 17, 2025
paramedics in surgical gloves and masks
How Health Choices and Legal Actions Intersect After an Injury
Health care
July 16, 2025
a woman giving a key
How Probate Planning Shapes the Future of Your Estate and Family Care
Health
July 16, 2025
a woman with kinesio tapes on her back arm
How communities and healthcare providers can address slip and fall injuries with legal awareness
Health care
July 16, 2025

You Might also Like

FDA Gives Approval for Lap-Band Use With Less Obese Patients

February 17, 2011

Meditate Your Way to Longer Telomeres; Keep Aging at Bay?

January 31, 2012

SaaS Firm Crowdfunds “People-Focused” Image Sharing

January 25, 2014

Preventing Alzheimer’s Before Disease Onset: A Key Expert Weighs In

June 15, 2012
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?